Amalgamated Bank Sells 1,942 Shares of Houlihan Lokey, Inc. (NYSE:HLI)

Amalgamated Bank cut its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 6.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,494 shares of the financial services provider’s stock after selling 1,942 shares during the quarter. Amalgamated Bank’s holdings in Houlihan Lokey were worth $3,573,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Ameritas Investment Partners Inc. grew its position in shares of Houlihan Lokey by 0.5% during the first quarter. Ameritas Investment Partners Inc. now owns 18,293 shares of the financial services provider’s stock worth $2,345,000 after purchasing an additional 97 shares in the last quarter. Park Avenue Securities LLC boosted its stake in Houlihan Lokey by 1.4% in the 2nd quarter. Park Avenue Securities LLC now owns 8,532 shares of the financial services provider’s stock worth $1,151,000 after purchasing an additional 120 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Houlihan Lokey by 12.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,139 shares of the financial services provider’s stock valued at $137,000 after buying an additional 123 shares in the last quarter. Portside Wealth Group LLC raised its position in shares of Houlihan Lokey by 6.3% during the second quarter. Portside Wealth Group LLC now owns 2,224 shares of the financial services provider’s stock valued at $300,000 after buying an additional 131 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. lifted its holdings in shares of Houlihan Lokey by 27.7% in the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 746 shares of the financial services provider’s stock worth $100,000 after buying an additional 162 shares in the last quarter. 78.07% of the stock is owned by institutional investors.

Insider Transactions at Houlihan Lokey

In related news, Director Gillian Beth Zucker sold 200 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $152.28, for a total transaction of $30,456.00. Following the transaction, the director now directly owns 6,801 shares in the company, valued at approximately $1,035,656.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, General Counsel Christopher M. Crain sold 1,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total value of $155,290.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Gillian Beth Zucker sold 200 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $152.28, for a total value of $30,456.00. Following the transaction, the director now owns 6,801 shares of the company’s stock, valued at approximately $1,035,656.28. The disclosure for this sale can be found here. In the last quarter, insiders sold 19,619 shares of company stock worth $2,818,759. 25.97% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Keefe, Bruyette & Woods reaffirmed a “market perform” rating and set a $154.00 target price (up from $139.00) on shares of Houlihan Lokey in a research note on Wednesday, July 31st. JPMorgan Chase & Co. cut their price objective on Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating for the company in a research report on Wednesday, July 31st. Wells Fargo & Company began coverage on Houlihan Lokey in a research report on Thursday, September 12th. They issued an “underweight” rating and a $149.00 target price on the stock. UBS Group raised their price target on Houlihan Lokey from $157.00 to $170.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Finally, Morgan Stanley decreased their price objective on Houlihan Lokey from $148.00 to $146.00 and set an “equal weight” rating on the stock in a report on Wednesday, September 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $149.60.

Houlihan Lokey Trading Up 1.2 %

HLI opened at $160.30 on Monday. The stock has a 50-day moving average of $150.66 and a 200 day moving average of $137.59. Houlihan Lokey, Inc. has a 12 month low of $94.67 and a 12 month high of $160.89. The firm has a market cap of $10.99 billion, a P/E ratio of 39.00 and a beta of 0.67.

Houlihan Lokey (NYSE:HLI) last announced its earnings results on Tuesday, July 30th. The financial services provider reported $1.22 EPS for the quarter, hitting analysts’ consensus estimates of $1.22. Houlihan Lokey had a return on equity of 18.80% and a net margin of 15.30%. The firm had revenue of $514.00 million during the quarter, compared to analysts’ expectations of $508.70 million. During the same quarter in the previous year, the business earned $0.89 EPS. The company’s quarterly revenue was up 23.6% on a year-over-year basis. On average, research analysts forecast that Houlihan Lokey, Inc. will post 5.64 earnings per share for the current fiscal year.

Houlihan Lokey Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Sunday, September 15th. Stockholders of record on Tuesday, September 3rd were paid a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.42%. The ex-dividend date was Tuesday, September 3rd. Houlihan Lokey’s dividend payout ratio is currently 55.47%.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.